HARP - Harpoon Therapeutics EPS misses by $0.01 misses on revenue August, 05 2020 04:56 PM Harpoon Therapeutics Inc. Harpoon Therapeutics (NASDAQ:HARP): Q2 GAAP EPS of -$0.51 misses by $0.01.More news on: Harpoon Therapeutics, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...